F43.1 F32
Conditions
Interventions
Group 1: NET
weekly, 10*100 min
period of time: 10 weeks
Group 2: NET
weekly, 10*100 min
Adjuvant endurance training:
Moderate endurance training (jogging)
1x weekly 45 min training group
2x weekly 4
Sponsors
Klinische Psychologie und PsychotherapieUniversität des Saarlandes
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants need to be (1) member of a German health insurance (as it is mandatory to be registered as a recognised refugee in Germany). Further inclusion criteria are diagnosis of (2) PTSD and clinical relevant (3) depression symptoms, a (4) minimum age of 18 years, at least (5) one year (pre study) of no endurance sports training and (6) no experience of endurance sports in the past (i.e., not more than one weekly unit of endurance sports during the last two years and no competitive practice in endurance sports)
Exclusion criteria
Exclusion criteria: Exclusion criteria are (1) cardiovascular diseases that preclude participation in moderate endurance training (including serious systemic diseases, cardiac insufficiency under resting conditions, coronary stenosis with angina pectoris, severe cardiac arrhythmia, and acute illnesses, such as acute infections, severe electrolyte imbalance, recent heart attacks, heart wall aneurism). Additionally, participants with (2) acute psychosis, (3) acute suicidal behavior and (4) eating disorders (due to the risk of abusing physical activity for weight loss), as well as (5) pregnant participants, and (6) participants with enduring substance abuse disorders/ enduring drug and alcohol abuse are excluded. For patients treated with medication, the administration of medication is kept constant until follow-up (in consultation with the doctor). The medication is documented and analysed as a covariate in statistical analyses. The use of benzodiazepines leads to exclusion from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre (pre intervention): Psychological assessment to test the indication of trauma-focused psychotherapy and to examine eligibility criteria: SCID-I, BSCL (General symptom severity) CAPS (symptom severity in PTSD) WAEC (War and Adversities Exposure Checklist) HAM-D (symptom severity in depression) Medical assessment of physical eligibility criteria: medical history, spiroergometry, treatmill ergometry, rest/stress ECG, blood test (complete blood count, clinical blood chemistry) Post (post intervention): Psychological assessment to examine symptom reduction: BSCL (General symptom severity) CAPS (symptom severity in PTSD) WAEC (War and Adversities Exposure Checklist) HAM-D (symptom severity in depression) Medical assessment to examine physiological parameters: medical history, spiroergometry, treatmill ergometry, rest/stress ECG, blood test (complete blood count, clinical blood chemistry) Follow-up (6 months post intervention): Psychological assessment to examine symptom reduction: BSCL (General symptom severity) CAPS (symptom severity in PTSD) WAEC (War and Adversities Exposure Checklist) HAM-D (symptom severity in depression) Medical assessment to examine physiological parameters: medical history, spiroergometry, treatmill ergometry, rest/stress ECG, blood test (complete blood count, clinical blood chemistry) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pre (before intervention): PSQI (symptom severity in sleep disorder) AKV (symptom severity in agoraphobia) Post (following intervention): PSQI (symptom severity in sleep disorder) AKV (symptom severity in agoraphobia) Follow-up (follow-up 6 months post intervention): PSQI (symptom severity in sleep disorder) AKV (symptom severity in agoraphobia) | — |
Countries
Germany
Contacts
Public ContactCharina Lüder
Arbeitseinheit für Klinische Psychologie und Psychotherapie
Outcome results
None listed